Edap Tms (NASDAQ:EDAP) Downgraded by StockNews.com to Sell

Edap Tms (NASDAQ:EDAP) was downgraded by equities research analysts at StockNews.com from a “hold” rating to a “sell” rating in a research report issued to clients and investors on Tuesday.

Separately, HC Wainwright reiterated a “buy” rating and set a $19.00 target price on shares of Edap Tms in a research report on Thursday, August 29th.

Edap Tms Price Performance

Edap Tms stock traded down $0.10 during mid-day trading on Tuesday, reaching $2.37. The company had a trading volume of 125,112 shares, compared to its average volume of 60,453. The business has a fifty day simple moving average of $2.71 and a 200 day simple moving average of $4.11. The company has a market cap of $87.94 million, a P/E ratio of -3.65 and a beta of 0.38. Edap Tms has a fifty-two week low of $2.27 and a fifty-two week high of $8.50. The company has a current ratio of 2.18, a quick ratio of 1.46 and a debt-to-equity ratio of 0.08.

Edap Tms (NASDAQ:EDAP) last issued its quarterly earnings data on Wednesday, August 28th. The medical equipment provider reported ($0.18) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.14) by ($0.04). Edap Tms had a negative return on equity of 44.21% and a negative net margin of 34.92%. The firm had revenue of $16.97 million for the quarter, compared to the consensus estimate of $17.16 million. On average, equities research analysts predict that Edap Tms will post -0.6 earnings per share for the current year.

Institutional Inflows and Outflows

Several hedge funds and other institutional investors have recently bought and sold shares of the stock. Virtu Financial LLC acquired a new position in Edap Tms in the first quarter valued at $82,000. Commonwealth Equity Services LLC grew its stake in shares of Edap Tms by 5.9% in the 2nd quarter. Commonwealth Equity Services LLC now owns 71,260 shares of the medical equipment provider’s stock valued at $388,000 after buying an additional 4,000 shares during the period. Redhawk Wealth Advisors Inc. acquired a new stake in Edap Tms in the third quarter valued at approximately $36,000. BNP Paribas Financial Markets increased its holdings in shares of Edap Tms by 23.7% during the third quarter. BNP Paribas Financial Markets now owns 23,000 shares of the medical equipment provider’s stock valued at $59,000 after acquiring an additional 4,400 shares in the last quarter. Finally, Orion Capital Management LLC raised its position in shares of Edap Tms by 10.4% during the third quarter. Orion Capital Management LLC now owns 69,800 shares of the medical equipment provider’s stock worth $178,000 after purchasing an additional 6,600 shares during the period. 62.74% of the stock is owned by institutional investors and hedge funds.

Edap Tms Company Profile

EDAP TMS SA, together with its subsidiaries, develops, produces, markets, distributes, and maintains a portfolio of minimally invasive medical devices for the treatment of urological diseases in Asia, France, the United States, and internationally. The company operates through High Intensity Focused Ultrasound (HIFU), Extracorporeal ShockWave Lithotripsy (ESWL), and Distribution Services (DIST) segments.